Imaging the Uterine Cervix - UltraSightHD™
|ClinicalTrials.gov Identifier: NCT01090635|
Recruitment Status : Completed
First Posted : March 22, 2010
Last Update Posted : February 4, 2011
The purpose of this study is to investigate the performance ability of the UltraSightHD™. The instrument will be assessed on characteristics such as focus quality, ability to image the entire cervix, and illumination. The information gathered from this study will provide data that will be used to determine which settings provide the best imaging outcome for the cervix for a simple screening instrument. Further, this information will serve as the foundation in the development of more advanced follow-on imaging devices.
The primary objectives of this study are to:
- Determine if the light source provides sufficient illumination of the cervix.
- Assess focus and overall image quality.
- Assess the functionality and ergonomics of the instrument's design.
|Condition or disease|
|Uterine Cervical Neoplasms|
|Study Type :||Observational|
|Actual Enrollment :||12 participants|
|Official Title:||Imaging the Uterine Cervix - UltraSightHD™|
|Study Start Date :||March 2010|
|Actual Primary Completion Date :||February 2011|
|Actual Study Completion Date :||February 2011|
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01090635
|United States, Hawaii|
|Dr. Nathan Fujita|
|Honolulu, Hawaii, United States, 96813|
|Principal Investigator:||Nathan Fujita, M.D.|